344 related articles for article (PubMed ID: 10545049)
1. Distribution of ten laminin chains in dystrophic and regenerating muscles.
Patton BL; Connoll AM; Martin PT; Cunningham JM; Mehta S; Pestronk A; Miner JH; Sanes JR
Neuromuscul Disord; 1999 Oct; 9(6-7):423-33. PubMed ID: 10545049
[TBL] [Abstract][Full Text] [Related]
2. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
3. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.
Patton BL; Miner JH; Chiu AY; Sanes JR
J Cell Biol; 1997 Dec; 139(6):1507-21. PubMed ID: 9396756
[TBL] [Abstract][Full Text] [Related]
4. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
[TBL] [Abstract][Full Text] [Related]
5. Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury.
Sorokin LM; Maley MA; Moch H; von der Mark H; von der Mark K; Cadalbert L; Karosi S; Davies MJ; McGeachie JK; Grounds MD
Exp Cell Res; 2000 May; 256(2):500-14. PubMed ID: 10772822
[TBL] [Abstract][Full Text] [Related]
6. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
7. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
8. Laminins during muscle development and in muscular dystrophies.
Gullberg D; Tiger CF; Velling T
Cell Mol Life Sci; 1999 Oct; 56(5-6):442-60. PubMed ID: 11212297
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S
Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132
[TBL] [Abstract][Full Text] [Related]
11. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
Straub V; Rafael JA; Chamberlain JS; Campbell KP
J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
[TBL] [Abstract][Full Text] [Related]
12. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.
Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K
Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186
[TBL] [Abstract][Full Text] [Related]
13. Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice.
Nakagawa M; Miyagoe-Suzuki Y; Ikezoe K; Miyata Y; Nonaka I; Harii K; Takeda S
Glia; 2001 Aug; 35(2):101-10. PubMed ID: 11460266
[TBL] [Abstract][Full Text] [Related]
14. Laminin isoforms in human extraocular muscles.
Kjellgren D; Thornell LE; Virtanen I; Pedrosa-Domellöf F
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4233-9. PubMed ID: 15557425
[TBL] [Abstract][Full Text] [Related]
15. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
Gawlik KI; Holmberg J; Durbeej M
Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
17. Abnormal localization of laminin subunits in muscular dystrophies.
Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K
J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011
[TBL] [Abstract][Full Text] [Related]
18. Extraocular muscle is spared upon complete laminin alpha2 chain deficiency: comparative expression of laminin and integrin isoforms.
Nyström A; Holmblad J; Pedrosa-Domellöf F; Sasaki T; Durbeej M
Matrix Biol; 2006 Aug; 25(6):382-5. PubMed ID: 16782317
[TBL] [Abstract][Full Text] [Related]
19. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
Connolly AM; Pestronk A; Planer GJ; Yue J; Mehta S; Choksi R
Neurology; 1996 Mar; 46(3):810-14. PubMed ID: 8618688
[TBL] [Abstract][Full Text] [Related]
20. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
